Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

7.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.8K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

7.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.6K
Replicative Cell Senescence02:15

Replicative Cell Senescence

4.2K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.0K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

9.8K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.8K
T Cell Types and Functions01:24

T Cell Types and Functions

1.9K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Value of Lymphoid Infiltration and Aggregation in Cervical Cancer.

Cancers·2026
Same author

Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation.

Cancer discovery·2025
Same author

Dysfunctional CD11c<sup>-</sup>CD21<sup>-</sup> extrafollicular memory B cells are enriched in the periphery and tumors of patients with cancer.

Science translational medicine·2025
Same author

Dendritic cells type 1 control the formation, maintenance, and function of tertiary lymphoid structures in cancer.

bioRxiv : the preprint server for biology·2025
Same author

The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions.

Cancer cell·2024
Same author

Stromal mediated DNA damage promotes high grade serous ovarian cancer initiation.

bioRxiv : the preprint server for biology·2024

Related Experiment Video

Updated: Dec 9, 2025

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.7K

Type I interferons and related pathways in cell senescence.

Steven M Frisch1, Ian P MacFawn1

  • 1Department of Biochemistry and WVU Cancer Institute, West Virginia University, Morgantown, West Virginia, USA.

Aging Cell
|September 12, 2020
PubMed
Summary

Interferons, key immune signaling molecules, and cell senescence, a finite growth arrest, unexpectedly intersect. This review explores their bidirectional relationship, impacting immunity, aging, and disease.

Keywords:
DNA damagecellular immunologycellular senescenceinflammationlongevitysenescence

More Related Videos

Techniques to Induce and Quantify Cellular Senescence
06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

34.6K
A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
11:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

12.3K

Related Experiment Videos

Last Updated: Dec 9, 2025

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.7K
Techniques to Induce and Quantify Cellular Senescence
06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

34.6K
A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
11:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

12.3K

Area of Science:

  • Immunology
  • Cell Biology
  • Aging Research

Background:

  • Discovery of interferons (1957) as critical immune signaling molecules.
  • Discovery of cell senescence (1961) as a finite, irreversible cell growth arrest.
  • Cell senescence linked to organismal aging and has implications for homeostasis and disease.

Purpose of the Study:

  • To critically review the bidirectional interplay between type I interferons and cell senescence.
  • To highlight the implications of this interplay for health and healthspan.

Main Methods:

  • Literature review of landmark discoveries in interferon and senescence research.
  • Analysis of studies investigating the interaction between interferons and cellular senescence.
  • Synthesis of current understanding of their roles in immunity, aging, and disease.

Main Results:

  • Interferons and cell senescence exhibit a complex, bidirectional relationship.
  • This interplay influences immune responses, aging processes, and disease states like cancer.
  • Understanding this interaction is crucial for advancing health and healthspan.

Conclusions:

  • The convergence of interferon and senescence research offers new insights into fundamental biological processes.
  • Targeting the interferon-senescence axis may hold therapeutic potential for age-related diseases and cancer.
  • Further research is warranted to fully elucidate and exploit this critical biological nexus.